Health

Results: 661-672 of 9503

People with type 2 diabetes who were increased to semaglutide 2 mg were as likely to achieve an HbA1c less than 7% and more likely to achieve greater than 5% weight loss than those who were switched to tirzepatide, in real-world data

Vertex Presents New Data on ALYFTREK® at European Cystic Fibrosis Conference

LivaNova Appoints Anne Liddy as Chief Legal Officer

K Pro, Owkin's AI scientist for biology, powered by multimodal patient data for smarter biopharma decision making.

Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

China's Leading Innovative Drug Developer for Allergic and Autoimmune Diseases LongBio Pharma Lists on Hong Kong Stock Exchange

New Health Economic Evidence Shows Health & Cost Benefits When Starting Dialysis at Home

Optellum Celebrates Accelerating Impact in Lung Cancer Care; Now at Over 250 Sites and Growing

Sectra's year-end report 2025/2026: Long-term investments drive growth and profit

PR Newswire associated0

Aphranel® Marks First Anniversary with EU MDR Certification, Arc™ Launch, and Over 150,000 Syringes Delivered

Azafaros Announces Publication of Phase 2 RAINBOW Study Data for Nizubaglustat in Molecular Genetics and Metabolism Journal

Lundbeck presents positive Phase IIb data for bocunebart (Lu AG09222; anti-PACAP mAb) in migraine prevention at the AHS congress